Genetic medicines have enormous power to direct and control biological processes. The challenge is reaching the target cells. BreezeBio is solving this problem with a fresh approach to targeted delivery of genetic medicines. Powered by NanoGalaxy®, our programmable delivery platform enables genetic payloads to move easily, reaching specific cells and tissues and controlling biological processes.
Explore Our Platform
The immune system is a delicate equilibrium: it must be powerful enough to eliminate threats but precise enough to spare healthy tissue. In autoimmune diseases, this balance is lost. At BreezeBio we are restoring harmony by precision delivery of genetic medicines to control specific processes. Importantly, while traditional delivery vehicles stimulate the very immune response they are trying to cure, our NanoGalaxy library features non-immunogenic nanoparticles that tilt the balance in the right direction. By delivering genetic medicine to the right immune cells in the right context, we restore immune balance and offer a path to a durable cure.
Explore Our Science
Precision Delivery for Immune Restoration Restoring immune balance with genetic medicine offers more than just symptom management—it provides a path to reset tolerance and achieve a durable cure. Our pipeline consists of therapies that are specific for the cause of the autoimmunity and otherwise leave the immune system intact and fully functional. Lead Program: Type 1 Diabetes Our lead program, BRZ-101, is a novel HNP-mRNA immune modulation therapy designed to induce antigen-specific immune tolerance in Type 1 Diabetes. In addition, we are advancing multiple programs for autoimmune disease and oncology.
See Our Pipeline
We are building with scientists, engineers, and innovators driven to push beyond today’s limits and shape the future of immune-modulating medicine.
View details
lilly 
Sequoia 
DSC investment 
Korea Investment 
PATHWAY 
Bio 
loftyrock 
DAYLI 